Research Summary
Dr. Handy’s research focuses on the relationship between coronary calcium buildup and diseases including cancer, heart disease, kidney disease and lung disease.
Selected Publications
View all on PubMed
Marshall CH, Fu W, Wang H, Baras AS, Lotan TL, Antonarakis ES. Prevalence of DNA repair gene mutations in localized prostate cancer according to clinical and pathologic features: association of Gleason score and tumor stage. Prostate Cancer Prostatic Dis. 2018 Aug 31. doi: 10.1038/s41391-018-0086-1. [Epub ahead of print] PubMed PMID: 30171229.
Handy CE, Quispe R, Pinto X, Blaha MJ, Blumenthal RS, Michos ED, Lima JAC, Guallar E, Ryu S, Cho J, Kaye JA, Comin-Colet J, Corbella X, Cainzos-Achirica M. Synergistic Opportunities in the Interplay Between Cancer Screening and Cardiovascular Disease Risk Assessment. Circulation. 2018 Aug 14;138(7):727-734. doi: 10.1161/CIRCULATIONAHA.118.035516. PubMed PMID: 30359131.
Handy CE, Antonarakis ES. Sipuleucel-T for the treatment of prostate cancer: novel insights and future directions. Future Oncol. 2018 Apr;14(10):907-917. doi: 10.2217/fon-2017-0531. Epub 2017 Dec 20. Review. PubMed PMID: 29260582; PubMed Central PMCID: PMC5925432.
Handy CE, Antonarakis ES. Sequencing Treatment for Castration-Resistant Prostate Cancer. Curr Treat Options Oncol. 2016 Dec;17(12):64. Review. PubMed PMID: 27822685.
Handy Marshall C, Nahas-Vigon J, Manesh R, Gelber AC. Just Beneath the Surface. N Engl J Med. 2018 Sep 6;379(10):968-973. doi: 10.1056/NEJMcps1802664. PubMed PMID: 30184453.